Summary
Ameren Corporation's subsidiary, Ameren Illinois Company, has filed a multi-year rate plan (MYRP) with the Illinois Commerce Commission (ICC) for the years 2024 through 2027. This filing proposes new base electric distribution service rates, seeking a 10.5% return on equity (ROE) and a common equity percentage of approximately 54%. The MYRP outlines a phased approach to rate increases, with a proposed deferral of 50% of the 2024 rate increase as a regulatory asset to be collected in 2026. The plan also includes annual revenue requirement reconciliations, subject to a cap, and excludes certain costs from this reconciliation, such as those for major storms or riders for specific services like energy efficiency and renewable energy credits. Additionally, the ROE will be subject to annual adjustments based on performance metrics, with incentives and penalties totaling 24 basis points. Investors should note that the ICC is expected to make a decision by December 2023, and the actual rate changes approved, as well as their sufficiency for cost recovery and earning a reasonable return, remain uncertain. This filing is a significant event for Ameren Illinois, as it will shape the company's revenue and profitability over the next four years. The inclusion of performance-based ROE adjustments introduces a variable element that could impact earnings, depending on Ameren Illinois' operational performance.
Key Highlights
- 1Ameren Illinois filed a Multi-Year Rate Plan (MYRP) with the ICC for 2024-2027.
- 2The MYRP requests a 10.5% Return on Equity (ROE) and a common equity percentage around 54%.
- 3Proposed initial rate increase for 2024 will be phased in, with 50% deferred as a regulatory asset for collection in 2026.
- 4Includes annual revenue requirement reconciliation with a 105% cap, excluding certain costs.
- 5ROE subject to annual adjustments based on seven performance metrics (incentives/penalties of 24 bps).
- 6ICC decision on the MYRP is expected by December 2023, with new rates effective January 2024.
- 7The sufficiency of approved rates for cost recovery and reasonable returns is currently uncertain.